about
Cell Microarray Technologies for High-Throughput Cell-Based Biosensors.Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancerClinical outcomes for T1-2N0-1 oral tongue cancer patients underwent surgery with and without postoperative radiotherapyOutcome of Local Excision Following Preoperative Chemoradiotherapy for Clinically T2 Distal Rectal Cancer: A Multicenter Retrospective Study (KROG 12-06).The role of adjuvant pelvic radiotherapy in rectal cancer with synchronous liver metastasis: a retrospective study.Postoperative adjuvant chemoradiotherapy in D2-dissected gastric cancer: is radiotherapy necessary after D2-dissection?Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer.Upfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastasesCorrelations of 3T DCE-MRI quantitative parameters with microvessel density in a human-colorectal-cancer xenograft mouse model.Evaluating Variations of Bladder Volume Using an Ultrasound Scanner in Rectal Cancer Patients during Chemoradiation: Is Protocol-Based Full Bladder Maintenance Using a Bladder Scanner Useful to Maintain the Bladder Volume?Morphologic change of rectosigmoid colon using belly board and distended bladder protocolMRI Risk Stratification for Tumor Relapse in Rectal Cancer Achieving Pathological Complete Remission after Neoadjuvant Chemoradiation Therapy and Curative Resection.Upfront Systemic Chemotherapy and Short-Course Radiotherapy with Delayed Surgery for Locally Advanced Rectal Cancer with Distant Metastases: Outcomes, Compliance, and Favorable Prognostic Factors.Comparison of elective inguinal node irradiation techniques in anal cancer.Locoregional relapse after gastrectomy with D2 lymphadenectomy for gastric cancer.Quantitative assessment of tumor responses after radiation therapy in a DLD-1 colon cancer mouse model using serial dynamic contrast-enhanced magnetic resonance imagingNutritional status of patients treated with radiotherapy as determined by subjective global assessment.Chemoradiotherapy in squamous cell carcinoma of the anal canal: a single institution experience.Circumferential resection margin positivity after preoperative chemoradiotherapy based on magnetic resonance imaging for locally advanced rectal cancer: implication of boost radiotherapy to the involved mesorectal fasciaThe location of locoregional recurrence in pathologic T3N0, non-irradiated lower rectal cancerEffects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers.Art therapy using famous painting appreciation maintains fatigue levels during radiotherapy in cancer patients.Variation in Practice Patterns of Korean Radiation Oncologists for Spine Metastasis between 2009 and 2014Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-confined hepatocellular carcinoma.Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy.Art therapy based on appreciation of famous paintings and its effect on distress among cancer patients.Recursive partition analysis of peritoneal and systemic recurrence in patients with gastric cancer who underwent D2 gastrectomy: Implications for neoadjuvant therapy consideration.Patterns of Care for Radiotherapy in the Neoadjuvant and Adjuvant Treatment of Gastric Cancer: A Twelve-Year Nationwide Cohort Study in Korea.Reduced pelvic field sparing anastomosis for postoperative radiotherapy in selected patients with mid-upper rectal cancerRectal Mucinous Adenocarcinoma: MR Imaging Assessment of Response to Concurrent Chemotherapy and Radiation Therapy-A Hypothesis-generating Study.Radiotherapy for painful bone metastases from hepatocellular carcinoma.High-dose helical tomotherapy with concurrent full-dose chemotherapy for locally advanced pancreatic cancer.Is local radiotherapy still valuable for patients with multiple intrahepatic hepatocellular carcinomas?Bladder filling variations during concurrent chemotherapy and pelvic radiotherapy in rectal cancer patients: early experience of bladder volume assessment using ultrasound scanner.Angiocentric T-cell and NK/T-cell lymphomas: radiotherapeutic viewpoints.A Randomized Phase 2 Study of Neoadjuvant Chemoradiaton Therapy With 5-Fluorouracil/Leucovorin or Irinotecan/S-1 in Patients With Locally Advanced Rectal Cancer.Gold nanoparticles enhance anti-tumor effect of radiotherapy to hypoxic tumor.Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery.Vertebral compression fractures after spine irradiation using conventional fractionation in patients with metastatic colorectal cancerTreatment outcome of radiation therapy and concurrent targeted molecular therapy in spinal metastasis from renal cell carcinoma.
P50
Q33858214-4E4F091D-0C6E-4DE1-969A-96887C333794Q33888813-398A6189-2A4B-4151-9BB8-C778D8223120Q33922087-6176EA6B-DCF9-4A28-816C-22BCAAE7EAFCQ34043383-CD86207B-9BE8-448B-943B-8C67BDEDEBDAQ34137566-3AE35CA0-A7EC-468D-B944-D876D316C3E6Q34255467-1D7521B9-8C9E-400A-A325-C9AAC3158F13Q35152348-6F762419-C4A1-4926-A00A-314C5E55C530Q35206160-13D9734C-DFF9-4188-9F25-8C74547C9091Q35361001-983EE262-29E9-47CD-9479-2F961EAFD3E6Q35651188-2610ED91-263A-4DFC-AB90-A6ECCF39DBBFQ35824242-EB521DDE-2EBD-457C-AF95-AA60F3DD4E1CQ35885124-56581126-895C-46D7-AAB4-5EF185FBC6DAQ36106616-3DA2EBE9-243F-40E9-8345-53641786FEB9Q36196016-DB2213AC-F1F3-47BC-989D-CF19F33E025EQ36292688-0B42B339-58B7-4DDA-839A-7E94119DB899Q36347971-6FBE8B29-41AC-44A9-8068-9A91BDE3A38DQ36395257-F8845005-E54E-44D4-9A62-0C5DD65B7726Q36786775-11CDCD55-C1EC-408D-8356-13E154D6D3EDQ36949323-99575A43-F58A-4BD0-8A52-D55A6E45EB79Q37015364-525CAF16-92B6-4BE7-808E-E401CE66541BQ37061363-F7E54DA5-E252-49A4-922F-E06128B17FD6Q37079055-8105AD05-C47C-4E22-949F-D202A758E180Q37097528-544B7EB2-AD20-4835-B155-E4D685318A1DQ37297239-43744F1E-0438-4BDE-A197-AE2227F6CBC2Q37536970-1026C311-5321-426A-9E5B-86B3ACBF365EQ38404002-DA1AB3CA-F80F-4618-94A6-A89579E8EE0AQ38803935-724CE67A-BFAF-410E-9123-E5D899CF7BC3Q38917073-87A3C4D5-5587-411A-9CDE-BD809001CD06Q39103454-C6254AD3-DCA2-41D7-9BFF-BCD7A01E7973Q39315430-6B0BBB47-A0C8-4FB1-A02B-AEC419897577Q39369201-7944411B-0B07-4125-96CB-C39DA4329B49Q39659101-538528BE-CFBC-4D55-9C56-30731AEDC209Q39931417-0095E690-12C6-4107-904B-BF3F070891E3Q40011137-4DFD1C1E-D8C6-46CB-9416-47A717E1679AQ40498958-D24EC95C-A37F-4949-8665-CCC157471FFBQ41115604-3C760459-3E2E-40BC-8AF9-84611A4386BCQ41475959-4B06F324-A297-445C-8B2C-F0A4E9E7E918Q41594853-98A0DE7D-39B7-44B5-A846-4F6E2DFC84CDQ41848565-70859C59-6464-4C54-A123-653C8A451F59Q42427607-A4FA0023-5044-481E-BC18-B52B00DFDBD8
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
Woong Sub Koom
@ast
Woong Sub Koom
@en
Woong Sub Koom
@es
Woong Sub Koom
@nl
type
label
Woong Sub Koom
@ast
Woong Sub Koom
@en
Woong Sub Koom
@es
Woong Sub Koom
@nl
prefLabel
Woong Sub Koom
@ast
Woong Sub Koom
@en
Woong Sub Koom
@es
Woong Sub Koom
@nl
P31
P496
0000-0002-9435-7750